Related Experiment Videos
Peripheral T-cell lymphoma with unique immunologic features
A Sheikha1, M al-Janadi, A al-Saigh
1Department of Clinical and Laboratory Hematology, King Saud University Medical College, Abha, Saudi Arabia.
Cancer
|February 1, 1993
Summary
Malignant T-cells in peripheral T-cell lymphoma show increased autologous mixed lymphocyte reactions (AMLR), suggesting a role in disease pathogenesis. This contrasts with decreased allogeneic reactions, highlighting unique immune responses in lymphoma.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Autologous mixed lymphocyte reaction (AMLR) is a key immunoregulatory process in human immune disorders.
- Peripheral T-cell lymphoma (PTCL) involves malignant T-cells with altered immune functions.
Purpose of the Study:
- To investigate the phenotype and response of malignant T-cells from PTCL patients in AMLR and allogeneic mixed lymphocyte reactions (MLR).
- To study lymphokine secretion by these T-cells.
Main Methods:
- Proliferative response assessed via tritiated 3H-thymidine incorporation assay for AMLR and allogeneic MLR.
- Interleukin-2 (IL-2) production measured using an IL-2-dependent T-cell line (CTLL) in a cytotoxic assay.
- B-cell growth and differentiation factor activity analyzed by enzyme-linked immunosorbent assay.
Main Results:
- Malignant lymph node T-cells from PTCL patients characteristically showed increased AMLR (12/14 cases).
- Blood T-cells exhibited decreased AMLR, while both lymph node and blood T-cells displayed decreased allogeneic MLR.
- CD2 and CD3 antigen expression/deficiency on malignant T-cells did not impact AMLR outcomes.
Conclusions:
- Malignant T-cells in PTCL demonstrate a propensity to proliferate in AMLR.
- The augmented AMLR and deficient allogeneic MLR in these cells suggest autologous recognition events are crucial in PTCL immunopathogenesis.